TagsHepatology 
Treatment on Antibiotic Resistance in Helicobacter Pylori 

Treatment on Antibiotic Resistance in Helicobacter Pylori Helicobacter pylori (H. pylori) is a bacterium that infects more than half of the worldwide population. H. pylori infection is the main cause of chronic gastritis and the etiological agent fo...

Mar 16, 2021
Moving Forward and Beyond - What’s Next for HCV in Hong Kong

Current Handling of HCV Treatment With the current approach of hepatitis C virus (HCV) treatment, Hong Kong has aligned itself with the World Health Organization (WHO) strategy to eliminate viral hepatitis as a major public health threat by 2030 1 ....

Jun 15, 2020
A Change for Better Management of HBV Infection – When and How?

Pharmacological Advantages of TAF over TDF Both TDF and TAF are recommended as the first-line therapy for CHB management 5 . However, TAF is more stable than TDF in plasma and delivers the active metabolite to hepatocytes more efficiently, allowing ...

Mar 16, 2020